Profit

Prabhudas Lilladher's View On Sun Pharma

PUBLISHED ON: November 7, 2016 | Duration: 13 min, 05 sec

facebooktwitteremailkoo
loading..
Ajay Bodke, CEO and chief portfolio manager for PMS at Prabhudas Lilladher, said if the Halol and Mohali plants get an all-clear from US regulator, the stock could be re-rated.
ALSO WATCH
Sun Pharma Q4 Profit In Line With Estimates

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com